Search Within

Steven M Sugarman

Formats
  1. Meeting Abstract (23)
  2. Journal Article (16)
Groups
  1. Breast Medicine Service (39)
  2. Department of Medicine (39)
  3. Solid Tumor Oncology Division (39)
  4. Survivorship Research (39)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (32)
  6. Epidemiology and Biostatistics (27)

More Groups

People
  1. Clifford Hudis (37)
  2. Larry Norton (29)
  3. Chau Dang (23)
  4. Gabriella D'Andrea-Carlino (20)
  5. Diana Lake (17)
  6. Sujata Patil (17)

More People

Years
  1. 2021 (1)
  2. 2017 (3)
  3. 2016 (3)
  4. 2015 (3)
  5. 2014 (2)
  6. 2011 (4)

More Years

Publications
  1. Breast Cancer Research and Treatment (11)
  2. Journal of Clinical Oncology (10)
  3. Cancer Research (7)
  4. Clinical Breast Cancer (4)
  5. Clinical Cancer Research (3)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Springer (11)
  2. American Association for Cancer Research (10)
  3. American Society of Clinical Oncology (10)
  4. Elsevier Inc. (5)
  5. Oxford University Press (2)
  6. Pergamon-Elsevier Science Ltd (1)

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tanespimycin (an Hsp90 inhibitor) and trastuzumab is an active combination in patients (pts) with Her2-positive trastuzumab-refractory metastatic breast cancer (MBC): Phase 2 trial
    Meeting Abstract

    Modi, S.; Stopeck, A.; Kinden, H.; Sugarman, S.; Ma, W.; Solit, D.; Kersey, K.; Johnson, R.; Hannah, A. L.; Hudis, C.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
    Journal Article

    Deng, G.; Vickers, A.; Yeung, S.; D'Andrea, G.; Xiao, H.; Heerdt, A.; Sugarman, S.; Troso-Sandoval, T.; Seidman, A.; Hudis, C.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
    Meeting Abstract

    Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Norton, L.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save